Three Dimensional Ultrasonographic Detection of Human Ovulation

Launched by UNIVERSITY OF SASKATCHEWAN · May 22, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how well two types of ultrasound—2D and 3D—can detect whether women are ovulating or not. Ovulation is important for fertility, and the study aims to see if one type of ultrasound is better than the other for diagnosing ovulation disorders. The trial is currently recruiting participants who are healthy biological females aged between 18 and 40 with regular menstrual cycles, meaning their periods come every 21 to 35 days.

To participate, women must not have certain health conditions, such as being underweight or overweight, being pregnant or breastfeeding, or having a history of infertility or reproductive surgeries. They also need to avoid substances like tobacco and hormonal medications that could affect their reproductive health. If eligible, participants can expect to undergo ultrasounds to help researchers understand which method works best for detecting ovulation. This study could help improve how doctors diagnose and treat ovulation-related issues in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Healthy biological females
• • Regular menstrual cycles (21-35 days)
• Exclusion Criteria:
• • BMI \<18 or \>30
• • Pregnancy
• • Breastfeeding mothers
• • History of infertility
• • History of hysterectomy or oophorectomy
• • Reproductive health issues that can interfere with study outcomes
• • Smoking
• • Not on any hormonal medication that affects reproduction (including hormonal contraception)
• • History of metabolic syndrome or untreated thyroid disease
• * Contra-indication to non-steroidal anti-inflammatory drug (NSAID) use. These include:
• • Gastric ulcers or gastro-intestinal bleeding
• • History of myocardial infarction or a coronary artery bypass
• • Cerebrovascular disease
• • Hypertension
• • Chronic or acute renal failure
• • Severe liver disease
• • Nasal polyp syndrome

Trial Officials